Molecure (WSE: MOC)

Last close As at 01/11/2024

20.00

0.08 (0.40%)

Market capitalisation

281m

Latest Insights

View More

Healthcare | Flash note

Molecure — Progressing the validation of mRNA platform

Healthcare | Update

Molecure — Q323 report highlights clinical progress

Healthcare | Update

Molecure — Striving to maximise clinical potential

Healthcare | Update

Molecure — Ramp-up in preparation for busy clinical year

molecure01

Sector

Healthcare

Balance Sheet

Forecast net debt (PLNm)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 2.0 10.6 36.1
Relative 1.6 (10.2) 8.2
52 week high/low 25.6gr/14.5gr

Financials

Edison Investment Research is terminating coverage on Molecure (MOC). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Y/E Dec Revenue (PLNm) EBITDA (PLNm) PBT (PLNm) EPS (fd) (gr) P/E (x) P/CF (x)
2021A 1.5 (14.9) (13.6) (98.0) N/A N/A
2022A 1.6 (17.3) (15.3) (109.0) N/A N/A
2023E N/A N/A N/A N/A N/A N/A
2024E N/A N/A N/A N/A N/A N/A

Thematics

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free